Senti Biosciences Holdings, Inc. — Form SCHEDULE 13D/A
Filed September 11, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
Celadon Partners SPV 24 filed an amended Schedule 13D/A regarding Senti Biosciences Holdings, Inc. on 2026-09-11. The filing discloses the filer's address as Suite 2810-12, 28/F, One Pacific Place, 88 Queensway, Admiralty, Hong Kong. Specific ownership percentages, share counts, acquisition dates, or material changes to beneficial ownership are not provided in this document header.
Why this rating
Routine amendment to ownership disclosure form; no concrete ownership changes, dollar amounts, or material facts disclosed in available filing text.
See more from September 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.